[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369388-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369388-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-the-tumor-microenvironment-in-hnscc-resistance-and-targeted-therapy","The role of the tumor microenvironment in HNSCC resistance and targeted therapy","","Head and neck squamous cell carcinoma (HNSCC) continues to have poor outcomes due to persistent therapeutic resistance and limited effective interventions. This review explains how the tumor microenvironment (TME)—comprising non-malignant cells and their metabolites—shapes HNSCC growth, invasion, metastasis, and resistance. Key TME components, including TAMs, Tregs, MDSCs, CAFs, the extracellular matrix, and altered metabolic programs, are analyzed for their roles in limiting responses to chemotherapy, radiotherapy, targeted therapy, and immunotherapy, and for guiding emerging TME-targeted strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-the-tumor-microenvironment-in-hnscc-resistance-and-targeted-therapy/369388/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-the-tumor-microenvironment-in-hnscc-resistance-and-targeted-therapy/369388.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-16","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does HNSCC often show resistance to multiple treatments?","Question",{"text":63,"@type":64},"The tumor microenvironment (TME) creates a supportive ecosystem that promotes tumor progression and treatment resistance. Its cellular and non-cellular components help cancer cells evade immune control and resist therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which TME components are highlighted as major contributors to resistance?",{"text":68,"@type":64},"The review focuses on tumor-associated macrophages (TAMs), regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), the extracellular matrix, and reprogrammed metabolic processes and products.",{"name":70,"@type":61,"acceptedAnswer":71},"How can targeting the TME improve outcomes for HNSCC?",{"text":72,"@type":64},"Therapies directed at TME components aim to disrupt mechanisms that drive resistance, thereby increasing sensitivity to chemotherapy, radiotherapy, targeted therapy, and immunotherapy and reducing treatment failure.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369388,1791305055,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 01 April 2025  \nDOI 10.3389/fimmu.2025.1554835  \nOPEN ACCESS  \nEDITED BY  \nWenxue Ma,  \nUniversity of California, San Diego, United States  \nREVIEWED BY  \nSadhna Aggarwal,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nSilvia D’Amico,  \nNational Research Council (CNR), Italy  \n*CORRESPONDENCE  \nPeng Zhang  \n [zhangpeng@link.cuhk.edu.hk](zhangpeng@link.cuhk.edu.hk)  \n†These authors have contributed equally to this work  \nRECEIVED 03 January 2025  \nACCEPTED 10 March 2025  \nPUBLISHED 01 April 2025  \nCITATION  \nGuo Z, Li K, Ren X, Wang X, Yang D, Ma S, Zeng X and Zhang P (2025) The role of the tumor microenvironment in HNSCC resistance and targeted therapy.  \nFront. Immunol. 16:1554835 .  \ndoi: 10.3389/fimmu.2025.1554835  \nCOPYRIGHT  \n© 2025 Guo, Li, Ren, Wang, Yang, Ma, Zeng and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe role of the tumor microenvironment in HNSCC resistance and targeted therapy  \nZhaomeng Guo †, Kang Li †, Xiaotong Ren †, Xijia Wang, Dunhui Yang, Shibo Ma, Xianhai Zeng and Peng Zhang*  \nDepartment of Otolaryngology, Longgang Otolaryngology hospital & Shenzhen Key Laboratory of Otolaryngology, Shenzhen Institute of Otolaryngology, Shenzhen, Guangdong, China  \nThe prognosis for head and neck squamous cell carcinoma (HNSCC) remains unfavorable, primarily due to signiﬁcant therapeutic resistance and the absence effective interventions. A major obstacle in cancer treatment is the persistent resistance of cancer cells to a variety of therapeutic modalities. The tumor microenvironment (TME) which includes encompasses all non-malignant components and their metabolites within the tumor tissue, plays a crucial role in this context. The distinct characteristics of the HNSCC TME facilitate tumor growth, invasion, metastasis, and resistance to treatment. This review provides a comprehensive overview of the HNSCC TME components, with a particular focus on tumor-associated macrophages (TAMs), regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), cancer-associated ﬁbroblasts (CAFs), the extracellular matrix, reprogrammed metabolic processes, and metabolic products. It elucidates their contributions to modulating resistance to chemotherapy, radiotherapy, targeted therapy, and immunotherapy in HNSCC, and explores novel therapeutic strategies targeting the TME for HNSCC management.  \nKEYWORDS  \ntumor microenvironment, HNSCC, target therapy, resistance, TAMs  \n1 Introduction  \nCurrently, about 90% of head and neck cancers are classiﬁed as head and necksquamous cell carcinoma (HNSCC) (1) . HNSCC is the sixth most prevalent cancer globally, with over 870,000 new cases diagnosed and more than 450,000 deaths annually (2) . This malignancy primarily affects the mucosal surfaces of four key anatomical regions: the oral cavity, sinuses, pharynx, and larynx. The principal risk factors contributing to the development of HNSCC include tobacco use, excessive alcohol consumption, and human papillomavirus (HPV) infection (3) . HNSCC is frequently diagnosed at a locally advanced or distant metastatic stage, which signiﬁcantly compromises patients’ quality of life. The disease is characterized by a high propensity for metastasis and recurrence, a poor response to conventional therapies, and notable resistance (4, 5) . The ﬁve-year survival rate post-  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ndiagnosis is approximately 50%, with nearly 30% of patients experiencing treatment failure and cancer recurrence (6, 7) . Consequently, there is an urgent need to de","cbCaifLdF7b7xdeO","https://ap.wps.com/l/cbCaifLdF7b7xdeO","pdf",886927,13,"English","# Introduction\n# Role of TME Components in Therapy Resistance\n## Tumor-Associated Macrophages (TAMs)\n## Regulatory T Cells (Tregs)\n## Myeloid-Derived Suppressor Cells (MDSCs)\n## Cancer-Associated Fibroblasts (CAFs)\n## Extracellular Matrix and Metabolic Reprogramming\n# Therapeutic Strategies Targeting the TME","[{\"question\":\"Why does HNSCC often show resistance to multiple treatments?\",\"answer\":\"The tumor microenvironment (TME) creates a supportive ecosystem that promotes tumor progression and treatment resistance. Its cellular and non-cellular components help cancer cells evade immune control and resist therapy.\"},{\"question\":\"Which TME components are highlighted as major contributors to resistance?\",\"answer\":\"The review focuses on tumor-associated macrophages (TAMs), regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), the extracellular matrix, and reprogrammed metabolic processes and products.\"},{\"question\":\"How can targeting the TME improve outcomes for HNSCC?\",\"answer\":\"Therapies directed at TME components aim to disrupt mechanisms that drive resistance, thereby increasing sensitivity to chemotherapy, radiotherapy, targeted therapy, and immunotherapy and reducing treatment failure.\"}]","The role of the tumor microenvironment in HNSCC resistance and targeted therapy | PDF",1790182359,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73ccff2ee7c1279746f6a07f670022ea.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa98efb0bf7c6e9ddffd0b5bfb025bf3.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b32aa46b34ec2a760e06485fbc83aa01.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eec82e3a53c1d9aa0fd6e4c148105818.webp",980,1385]